The Personalized Medicine Foundation (PMF) a leading cancer patient advocacy organization focused on patient education
Alcensa, Xalkori, and several other precision cancer medicines target ALK positive lung cancer and improve treatment.
Cancer diagnoses drop as many skip screening due to COVID-19. COVID may lead to 10,000 excess cancer deaths
Lobrena - a third generation ALK inhibitor drug with excellent CNS activity
The COVID-19 pandemic is creating a new normal-patients need to adapt to reduce risk and understand treatment decisions.
3D Bioprinting is and innovative approach to provide a revolutionized personal treatment plan for cancer patients
The sudden, rapid death of cancer cells in response to cancer treatment causes metabolic and electrolyte disturbances.
Genomic testing identifies targets that can be treated with precision cancer medicines. ASCO 2020 update
Precision cancer medicines that target p53 protein mutations are currently being evaluated in clinical trials
Calquence side effects
Immunotherapy Halts Growth of Rare Stage IV Sarcoma
Paxalsib granted FDA fast track for Glioma
We need to know the latest info on liposarcomas in adult males
Need information on malignant plueral effusion in my 33 yr old daughte
Had BCG and GEM/DOC
I had IPMN and 30% of my pancreas resected Pathology of the cyst(post
Buccal squamous cell carcinoma
New UCSF trial for GBM now open: